Background: End-of-life communication is an essential component of high-quality care, but its potential mechanisms for improving care are not well understood.
Objectives: To summarise the potential mechanisms by which end-of-life communication may contribute to enhanced end-of-life care in any setting.
Design: An overview of systematic reviews, with a narrative synthesis of results. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Study quality was assessed using the AMSTAR (A MeaSurement Tool to Assess Reviews) tool.
Data Sources: CINAHL, MEDLINE, Cochrane, SSCI and PsycINFO databases, were searched from inception to January 2024. Manual searches were also conducted.
Eligibility Criteria For Selecting Studies: Systematic reviews (published in English) related to end-of-life communication, where the target population was adult patients in their last year of life, relatives, caregivers and/or healthcare professionals involved in communicating with dying patients.
Results: We reviewed 35 eligible studies. The reviews suggest potential mechanisms of effective end-of-life communication including collaborative decision-making, tailoring communication to individuals, using effective communication strategies and incorporating communication skills into practice. The reviews also highlighted barriers related to patients, professionals and organisations.
Conclusion: This review highlights a nuanced understanding of potential mechanisms of end-of-life communication, emphasising the need for tailored training, policy enhancements and interprofessional collaboration. It calls on healthcare professionals to reflect on their practices, advocating for co-designing a person-centred communication model that addresses patient preferences at the end of life. Importantly, in culturally diverse contexts, there is a need for a communication paradigm that embraces diversity to provide truly empathetic and effective end-of-life care. This concise roadmap may foster compassionate, dignified and effective end-of-life communication.
Trial Registration Number: Protocol registered with PROSPERO (CRD42022271433, 29 March 2022).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/spcare-2024-004904 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!